3D Cell Models Congress 2018
3D Cell Models Congress
24-25 January, 2018
Berlin, Germany

Driving forward 3D cell models for enhanced drug and therapeutic development

The Agenda

Download Full Agenda

We need some information to know where to send the link and how to address our email to you. Please note, a link to the PDF will also become immediately available once this form is submitted.

To prevent automated spam submissions leave this field empty.

Subject Access Requests: If you would like a copy of the data/information we hold about you, please email [email protected].

User Deletion Request: If you wish to have your information that is held by Kisaco Research deleted, please email [email protected].

For more information on Kisaco Research policy and procedures, please visit our Privacy Policy.

Why Attend

The 3D Cell Models Congress 2018 will present the latest developments and innovation in three-dimensional cell models including organoids, spheroids, and organ-on-a-chip, as well as bioprinting technologies.

Leading pharma and biotech companies and top academics will present their data on the applicability of 3D models in drug safety testing, disease modelling, personalized medicine, drug discovery and more.

The regulatory hurdles for the widespread implementation of these models will be addressed by the EMA and the FDA, allowing you to more effectively progress in your research. Dedicated networking sessions will facilitate collaborations to drive forward superior drug and therapeutic development.

80+
Attendees
20+
Speakers
6+
hours of networking

The Speakers

 

Dr. Uwe Marx

CEO
TissUse

Trained in human biology and medicine, Dr. Marx is an accomplished entrepreneur and the scientific founder of TissUse, a spin-off of the Institute of Biotechnology of the Technische Universität Berlin, Germany. Over the course of his fruitful career in biotechnology, Dr. Marx has pursued ever more lifelike structures that can mimic human biology in vitro. Prior to founding TissUse, Dr. Marx was head of the “Multi-Organ-Chip” program at the University and the scientific co-founder at two successful Germany-based biotechs, ProBioGen AG and VITA 34.

Dr. Uwe Marx

CEO
TissUse

Dr. Uwe Marx

CEO
TissUse

Trained in human biology and medicine, Dr. Marx is an accomplished entrepreneur and the scientific founder of TissUse, a spin-off of the Institute of Biotechnology of the Technische Universität Berlin, Germany. Over the course of his fruitful career in biotechnology, Dr. Marx has pursued ever more lifelike structures that can mimic human biology in vitro. Prior to founding TissUse, Dr. Marx was head of the “Multi-Organ-Chip” program at the University and the scientific co-founder at two successful Germany-based biotechs, ProBioGen AG and VITA 34.

 

Philip Hewitt

Global Head of early Non Clinical Safety (Liver and Kidney)
Merck KGaA

Philip Hewitt

Global Head of early Non Clinical Safety (Liver and Kidney)
Merck KGaA

Philip Hewitt

Global Head of early Non Clinical Safety (Liver and Kidney)
Merck KGaA
 

Magnus Ingelman-Sundberg

Karolinska Institutet

Magnus Ingelman-Sundberg

Karolinska Institutet

Magnus Ingelman-Sundberg

Karolinska Institutet
 

Dr. Suzanne Fitzpatrick

Senior Advisor for Toxicology
FDA

Dr. Suzanne Fitzpatrick

Senior Advisor for Toxicology
FDA

Dr. Suzanne Fitzpatrick

Senior Advisor for Toxicology
FDA
 

Tommy Andersson

Cardiovascular and Metabolic Diseases, Innovative Medicines and Early Development Biotech Unit
AstraZeneca R&D Mölndal

Tommy Andersson

Cardiovascular and Metabolic Diseases, Innovative Medicines and Early Development Biotech Unit
AstraZeneca R&D Mölndal

Tommy Andersson

Cardiovascular and Metabolic Diseases, Innovative Medicines and Early Development Biotech Unit
AstraZeneca R&D Mölndal
 

Robert Vries

Managing Director
Hubrecht Organoid Technology

Robert Vries

Managing Director
Hubrecht Organoid Technology

Robert Vries

Managing Director
Hubrecht Organoid Technology
 

Dr. Sonja Beken

Safety Working Party
European Medicines Agency

Dr. Sonja Beken

Safety Working Party
European Medicines Agency

Dr. Sonja Beken

Safety Working Party
European Medicines Agency
 

Professor Paul Gatenholm

Chemistry and Chemical Engineering
Biopolymer Technology

Professor Paul Gatenholm

Chemistry and Chemical Engineering
Biopolymer Technology

Professor Paul Gatenholm

Chemistry and Chemical Engineering
Biopolymer Technology
 

Josep Samitier

Director
Institute for Bioengineering of Catalonia

Josep Samitier

Director
Institute for Bioengineering of Catalonia

Josep Samitier

Director
Institute for Bioengineering of Catalonia
 

Dr. Yu Shrike Yang

Instructor of Medicine and Associate Bioengineer
Harvard Medical School

Dr. Yu Shrike Yang

Instructor of Medicine and Associate Bioengineer
Harvard Medical School

Dr. Yu Shrike Yang

Instructor of Medicine and Associate Bioengineer
Harvard Medical School
 

Adrian Britschgi

Lab Head MTT Discovery Oncology
Roche

Adrian Britschgi

Lab Head MTT Discovery Oncology
Roche

Adrian Britschgi

Lab Head MTT Discovery Oncology
Roche
 

Olivier Guenat

Head of Organs-on-Chip Technologies, ARTORG Center for Biomedical Engineering Research
University of Bern-Switzerland

Olivier Guenat

Head of Organs-on-Chip Technologies, ARTORG Center for Biomedical Engineering Research
University of Bern-Switzerland

Olivier Guenat

Head of Organs-on-Chip Technologies, ARTORG Center for Biomedical Engineering Research
University of Bern-Switzerland
 

Prof. Gabor Forgacs

Scientific Founder and Chief Scientific Officer
Modern Meadow, Inc.

Prof. Gabor Forgacs

Scientific Founder and Chief Scientific Officer
Modern Meadow, Inc.

Prof. Gabor Forgacs

Scientific Founder and Chief Scientific Officer
Modern Meadow, Inc.
 

Dr. Hansjoerg Keller

Senior Investigator
Novartis Institutes for Biomedical Research

Dr. Hansjoerg Keller

Senior Investigator
Novartis Institutes for Biomedical Research

Dr. Hansjoerg Keller

Senior Investigator
Novartis Institutes for Biomedical Research
 

Gianni Dal Negro

CIVM Diector, Integrated Biological Platform Sciences
GSK

Gianni Dal Negro

CIVM Diector, Integrated Biological Platform Sciences
GSK

Gianni Dal Negro

CIVM Diector, Integrated Biological Platform Sciences
GSK
 

Dr Noushin Dianat

CEO
Cyprio

Being a liver bioengineering enthusiast, in 2014, Noushin joined Laboratory of Colloids and Divided Materials (LCMD) at ESPCI Paris (The City of Paris Industrial Physics and Chemistry Higher Educational Institution) as a postdoctoral fellow and developed a novel 3D liver model adapted for high throughput drug screening through a collaborative project with Sanofi.

Dr Noushin Dianat

CEO
Cyprio

Dr Noushin Dianat

CEO
Cyprio

Being a liver bioengineering enthusiast, in 2014, Noushin joined Laboratory of Colloids and Divided Materials (LCMD) at ESPCI Paris (The City of Paris Industrial Physics and Chemistry Higher Educational Institution) as a postdoctoral fellow and developed a novel 3D liver model adapted for high throughput drug screening through a collaborative project with Sanofi.

 

Dr. Peter Loskill

Attract Group Manager Organ-on-a-Chip
Department of Cell and Tissue Engineering, Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB

Dr. Peter Loskill is Assistant Professor for Experimental Regenerative Medicine at the Eberhard Karls University Tübingen and head of the Fraunhofer Attract group Organ-on-a-Chip at the Fraunhofer Institute for Interfacial Engineering and Biotechnology (IGB) in Stuttgart, Germany. Dr. Loskill graduated in 2012 from Saarland University with a PhD in Physics focusing on Biointerface science.

Dr. Peter Loskill

Attract Group Manager Organ-on-a-Chip
Department of Cell and Tissue Engineering, Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB

Dr. Peter Loskill

Attract Group Manager Organ-on-a-Chip
Department of Cell and Tissue Engineering, Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB

Dr. Peter Loskill is Assistant Professor for Experimental Regenerative Medicine at the Eberhard Karls University Tübingen and head of the Fraunhofer Attract group Organ-on-a-Chip at the Fraunhofer Institute for Interfacial Engineering and Biotechnology (IGB) in Stuttgart, Germany. Dr. Loskill graduated in 2012 from Saarland University with a PhD in Physics focusing on Biointerface science.

 

Dr. Sébastien Cadau

Tissue Engineering and Cell Culture
BASF Beauty Care Solutions

Dr. Sébastien Cadau

Tissue Engineering and Cell Culture
BASF Beauty Care Solutions

Dr. Sébastien Cadau

Tissue Engineering and Cell Culture
BASF Beauty Care Solutions
 

Dr. Andrew Mearns Spragg

CEO & Founder
Jellagen Pty Ltd

Dr. Andrew Mearns Spragg

CEO & Founder
Jellagen Pty Ltd

Dr. Andrew Mearns Spragg

CEO & Founder
Jellagen Pty Ltd
 

Dr. Reyk Horland

VP Business Development
TissUse

Dr. Reyk Horland

VP Business Development
TissUse

Dr. Reyk Horland

VP Business Development
TissUse
 

Prof. James Hickman

NanoScience Technology Center, Chemistry, Biomolecular Science and Electrical Engineering
University of Central Florida

Prof. James Hickman

NanoScience Technology Center, Chemistry, Biomolecular Science and Electrical Engineering
University of Central Florida

Prof. James Hickman

NanoScience Technology Center, Chemistry, Biomolecular Science and Electrical Engineering
University of Central Florida

Event Partners

Media Partners

PARTNER WITH US

Based on your objectives, we can create bespoke packages designed specifically for you. Opportunities predominantly lie in 3 main categories: Thought Leadership, Branding, and Networking.

CONTACT US TO FIND OUT MORE

Interested in a media partnership?
We'd love to hear from you and how we can support one another to connect with the industry. Contact [email protected]

Venue

Mövenpick Hotel,Schöneberger Str. 3, 10963, Berlin, Germany

Movenpick Hotel Berlin, Schoeneberger Strasse 3, 10963 Berlin, Germany

Rate: €119.00 includes vat and buffet breakfast, single occupancy. To book a room telephone reservations + 49 (0) 30 23 006 186 or Email: [email protected]

For online reservations please visit the Group Reservations page

Always quote “KISACO RESEARCH LTD” when booking.

If you need to book more than two nights please contact the hotel directly and quote our code.

Mövenpick Hotel Berlin is a 4-star hotel located in the city centre of Berlin near the Anhalter Bahnhof S-Bahn train station and Berlin’s famous public square, Potsdamer Platz.

Conference Packages

Sending Your Team? Group Discounts Available!

Applicable for Primary Market, Service Provider and Industry Rates Only. Not available for Academic or ‘Start-Up’ rates

Book a Team of 3+ - Save an Additional 10% Off
Book a Team of 5+ - Save an Additional 15% Off

If you would like to register a team of 3 or more, please email [email protected] for your discount coupon code before registering. PLEASE NOTE: Discounts cannot be combined with Early Bird Pricing or any other discount or offer. If you have any questions about your registration, please call us on +44 (0)20 3696 2920

We accept the following cards through Stripe:
Preparing registration...

Book a Team to Save More!

PLEASE NOTE: Team Discounts are only available for Industry Pricing
Book a Team of 3+
 - Save an Additional 10% Off
Book a Team of 5+ - Save an Additional 15% Off

Payment Terms for 3D Cell Models Congress:

  • Please note that a €49 processing fee will apply to any invoices requested.
  • All Prices are in EUR and are exclusive of VAT @ 19%
  • All Early Bird discount prices, including Group Discounts, must be paid in full by deadlines provided above.
  • No discounts or offers can be combined with any other offer.
  • Please view our Cancellation Policy.
  • QUESTIONS? Please email [email protected].

Pass Features:

  • 3D Cell Models Congress - Access to all areas
  • Networking Sessions
  • Lunch and Refreshments
  • Complimentary Articles and Content

About Kisaco Research

Kisaco Research produces, designs and hosts B2B industry conferences, exhibitions and communities – focused on a specialized selection of topic areas.

Meet industry peers that will help build a career-changing network for life.

Learn from the mistakes of your peers as much as their successes—ambitious industry stalwarts who are happy to share not just what has made them successful so far but also their plans for future proofing their companies.

Note down the inspired insight that will form the foundation for future strategies and roadmaps, both at our events and through our online communities.

Invest both in your company growth and your own personal development by signing up to one of our events and get started.

Contact Us

Kisaco Research
Registered office address: 41a Maltby Street, London, SE1 3PA
+44 (0)20 3696 2920 | [email protected]
Place of registration: London, United Kingdom
Company number: 09316521

We need some information to know how best to respond to your request below.

To prevent automated spam submissions leave this field empty.

Subject Access Requests: If you would like a copy of the data/information we hold about you, please email [email protected].

User Deletion Request: If you wish to have your information that is held by Kisaco Research deleted, please email [email protected].

For more information on Kisaco Research policy and procedures, please visit our Privacy Policy.

Resources

Download Resource

We need some information to know where to send the link and how to address our email to you. Please note, a link to the PDF will also become immediately available once this form is submitted.

You may withdraw this consent at any time by emailing us at [email protected].
To prevent automated spam submissions leave this field empty.

Subject Access Requests: If you would like a copy of the data/information we hold about you, please email [email protected].

User Deletion Request: If you wish to have your information that is held by Kisaco Research deleted, please email [email protected].

For more information on Kisaco Research policy and procedures, please visit our Privacy Policy.